Close
CDMO Safety Testing 2026
Novotech

Press Releases

Sen-Jam Pharm Partners with Specialty Pharma Manufacturer to Provide Formulation and Chemistry, Manufacturing & Controls for Covid-19 Oral Therapeutic

Sen-Jam Pharmaceutical, an innovative life sciences company developing a portfolio of revolutionary anti-inflammatories by repurposing existing molecules for novel combination therapy, has entered a strategic partnership with KVK Tech. KVK Tech is a leading Specialty Pharmaceutical Manufacturing company that...

Gamma Biosciences Launches Initiative Through Mirus Bio to Develop Lipid-Polymer Nanocomplexes for In Vivo mRNA Delivery

Gamma Biosciences, a global life sciences company serving the advanced therapy market, announced an initiative through its subsidiary Mirus Bio, a leader in nucleic acid delivery technology, to develop novel, highly active lipid-polymer nanocomplexes for therapeutic mRNA delivery in...

Pfizer to supply UNICEF up to 4 million treatment courses of novel Covid-19 oral treatment, Paxlovid for low- and middle-income countries

Pfizer Inc. announced an agreement with UNICEF to supply up to 4 million treatment courses of its Covid-19 oral treatment, Paxlovid (nirmatrelvir tablets and ritonavir tablets), to 95 low- and middle-income countries, pending authorization or approval. This includes...

Akston Biosciences and Biolexis Collaborate to Launch a Room Temperature Stable 2nd Generation COVID-19 Vaccine in 130+ Countries

Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, and Biolexis, a division of Stelis Biopharma Limited (Stelis), announced that they have entered into a licensing, manufacturing and commercialization agreement for Akstonโ€™s AKS-452, a protein subunit COVID-19...

Peli BioThermal Launches Updated Credo ProEnvision Software

Peli BioThermal, the life science industryโ€™s cold chain partner from discovery to distribution, announces a growing number of enhancements to its CredoProEnvision track and trace software. CredoProEnvision 2.0 lays the groundwork for more significant software updates as Peli BioThermal...

Nutcracker Therapeutics Raises $167 Million in Series C Financing to Advance its mRNA Therapeutics and First-of-its-Kind Biochip-based Manufacturing Platform

Nutcracker Therapeutics, Inc., a biotech company developing RNA therapeutics using its proprietary biochip-based manufacturing platform, announced it has raised $167 million in Series C financing led by ARCH Venture Partners. The funds will allow the company to expand and...

Almac Pharma Services Expands Its Unique Ultra-Low Temperature Solutions for Advanced Therapy Medicinal Products

Almac Pharma Services, a member of the Almac Group providing innovative pharmaceutical development, manufacture and commercial services, has expanded its state-of-the-art, Ultra-Low Temperature commercial packaging, labelling and distribution solutions to support the launch of Advanced Therapy Medicinal Products (ATMPs)...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป